Cvs Pharmacy #04519 Durable Medical Equipment & Medical Supplies Location: 205 Highway 16 West, Carthage, Mississippi 39051 Phone: (601) 267-9195 |
Wal-mart Pharmacy 10-0305 Durable Medical Equipment & Medical Supplies Location: 905 Highway 16 W, Carthage, Mississippi 39051 Phone: (601) 267-5999 |
Carthage Discount Drug #15737 Durable Medical Equipment & Medical Supplies Location: 602 Highway 16 E, Carthage, Mississippi 39051 Phone: (601) 267-4533 |
Cook Medical Supply Carthage Durable Medical Equipment & Medical Supplies Location: 404 Highway 16 E, Carthage, Mississippi 39051 Phone: (601) 267-6334 |
Carthage Eye Clinic Pa Medicare Supplier Location: 201 Highway 16 E, Carthage, Mississippi 39051 Phone: (601) 267-9351 |
News Archive
The measurement of activity levels may help distinguish patients with unipolar depression from those with bipolar disorder when they are in a remitted or mild/moderate depressive state, say researchers.
A new review by the International Osteoporosis Foundation Chronic Inflammation and Bone Structure Working Group concludes that early and aggressive treatment of Rheumatoid Arthritis (RA) with biologic drugs, specifically biological disease-modifying anti-rheumatic drugs (DMARDs), may be most effective in halting progressive bone loss in patients with RA.
The Food and Drug Administration, along with the Centers for Disease Control and Prevention and the U.S. Department of Agriculture's Food Safety and Inspection Service, continues to work closely with the Rhode Island Department of Health and other states in the investigation of an outbreak of Salmonella Montevideo infections associated with certain Italian-style sausage products including salami/salame.
With a mortality rate estimated at 10%, the life-threatening condition known as thyroid storm (TS) demands rapid diagnosis and treatment and can benefit from new evidence-based guidelines for TS developed by researchers in Japan.
Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.
› Verified 9 days ago